Orphan Drug status in Europe is given to medicines with the potential to be safe and effective treatments for rare, life-threatening, or chronically debilitating conditions affecting no more than 5 people in 10,000 people.from Healthcare/Biotech-Industry-Economic Times https://ift.tt/3rmLYuK
via IFTTT
0 comments:
Post a Comment